Meet the Oxford and Thames Valley Trailblazers
Oxford PV
Oxford PV is accelerating the transition to an all-electric world, through the development of perovskite-based solar technology. With a groundbreaking world record for commercial-sized solar cell efficiency, it will be accelerating the adoption of solar energy at speed. Impressive growth propelled the company to secure over $140 million (£120 million) in investments, solidifying its position as a frontrunner in renewable energy.
Oxa
Oxa is accelerating the transition to self-driving technology with software and services that enable global enterprises to deploy autonomous technology into their operations safely, efficiently, and reliably. Anchored in a vision of Universal AutonomyTM -- software that enables any vehicle to be self-driving, anywhere – Oxa is already helping industries including agriculture, logistics and shared passenger transportation unlock the benefits of self-driving technology today.
Ivy Farm Technologies
Ivy Farm is on a mission to tackle one of the world’s biggest climate polluters – industrial agriculture. By applying innovative technology partly developed at Oxford University, alongside 50 scientists, it is growing real meat in a lab. Its technology is proven to scale: last year, it opened Europe’s largest cultivated meat 18,000 sqft pilot facility, capable of producing 2.8 tonnes of meat annually.
Tokamak Energy
Tokamak Energy is pursuing the global deployment of clean, affordable and secure fusion through the combined development of spherical tokamaks with high temperature superconducting (HTS) magnets. Remarkably, it broke records by achieving a plasma temperature of 100 million degrees Celsius last year, showcasing it’s cutting-edge technology and progress.
Diffblue
Diffblue is a pioneering Generative AI for Code enterprise, aiming to revolutionise software development. Originating from the University of Oxford's AI research group, it released its inaugural code-writing software in 2020. With over $40m in investment, esteemed clients like Goldman Sachs, S&P Global, Citi, JP Morgan, and AWS trust its innovations.
Beckley Psytech
Beckley Psytech is pioneering the development of rapid-acting, short-duration psychedelic medicines for neuropsychiatric conditions like depression and substance abuse. Combining world-leading psychedelic science with extensive drug development expertise Beckley Psytech is on a mission to optimise patient outcomes, improve treatment opportunities and ease the burden these conditions have on individuals, healthcare systems and society.
Reaction Engines
Reaction Engines has developed ground-breaking thermal management technologies that provide a step change in performance, efficiency and sustainability across a range of industries including energy, automotive, aerospace, hypersonics and space. With a team of over 250 professionals spanning the UK and US, its award winning technology sets new standards in heat transfer.
Lunaz
Lunaz created the world’s first electric Jaguar, Bentley, Aston Martins, and Range Rovers, morphing their classic marques into EVs. It now up-cycles and electrifies industrial vehicles at scale and aims to deliver thousands of vehicles, saving millions of tonnes of embedded carbon. Lunaz boasts a £158M valuation, employs 130 staff, and aims to expand to 350 by 2024.
Oxford Ionics
Oxford Ionics, a world-leading innovator, is building the most powerful, accurate and reliable quantum computers. Founded in 2019 by Dr Chris Ballance and Dr Tom Harty, it combines the highest quality qubits – trapped ions – with a unique noiseless electronic qubit control technology to create unique technologies with transformative potential.
Oxford Space Systems
Oxford Space Systems creates innovative, lightweight deployable antennas to give improved performance, efficiency and cost effectiveness versus traditional designs. Its customers include Airbus, AAC Clyde Space and Space Norway, with strong institutional support from the European Space Agency, the UK Space Agency, the UK Defence Science and Technology Laboratory and the National Security Strategic Investment Fund.
PQShield
PQShield was the first cybersecurity company to develop quantum-safe cryptography on microchips, in applications, and in the cloud. With teams in Europe, Japan, the UK, and US, the company comprises a world-class collaboration of post-quantum cryptographers, researchers, and engineers, making it the industry's hub for cryptographic expertise. PQShield's customers include the likes of Collins Aerospace and Bosch.
ZeroAvia
ZeroAvia is at the forefront of zero-emission aviation, developing hydrogen-electric engines for aircraft. Focusing initially on engines for 10-20 seat aircraft by 2025 and 40-90 seat aircraft by 2027, the company has nearly 2,000 engine pre-orders from operators serving commercial passenger transport and cargo. ZeroAvia has twice broken the record for flying the world's largest hydrogen-electric-powered aircraft and is now working on a 76-seat demonstrator to deliver another groundbreaking milestone.
Oxford Quantum Circuits
Oxford Quantum Circuits harnesses quantum power to achieve unprecedented feats. Its technology opens doors to life-changing drug discoveries and revolutionary battery advancements. It also proudly holds the UK's most advanced quantum computer, propelling innovation into uncharted territory.
Nucleome Therapeutics
Nucleome Therapeutics employs machine learning, 3D genome analysis and functional validation technology to decipher the non-coding regions of DNA, comprising 98% of our genetic material. Notably, 90% of disease-associated genetic variations arise from these regions. Unravelling this 'dark matter' presents a substantial opportunity for drug discovery and development, paving the way for ground-breaking advances in medicine.
Oxford Quantum Circuits
Oxford Quantum Circuits harnesses quantum power to achieve unprecedented feats. Its technology opens doors to life-changing drug discoveries and revolutionary battery advancements. It also proudly holds the UK's most advanced quantum computer, propelling innovation into uncharted territory.
Nucleome Therapeutics
Nucleome Therapeutics employs machine learning, 3D genome analysis and functional validation technology to decipher the non-coding regions of DNA, comprising 98% of our genetic material. Notably, 90% of disease-associated genetic variations arise from these regions. Unravelling this 'dark matter' presents a substantial opportunity for drug discovery and development, paving the way for ground-breaking advances in medicine.
@diffbluehq | diffblue.com
@OxfordPV | oxfordpv.com
@Oxa_UA | oxa.tech
@ivyfarm_tech | ivy.farm
@TokamakEnergy | tokamakenergy.co.uk
@BeckleyPsytech | beckleypsytech.com
@PqShield | pqshield.com
@ZeroAvia | zeroavia.com
@ReactionEngines | reactionengines.co.uk
@Lunazdesign | lunaz.tech
@OxfordIonics | oxionics.com
@OxfordSpace | oxford.space
@OxfordQCircuits | oxfordquantumcircuits.com
@NucleomeTx | nucleome.com